# Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation

> **NCT04994249** · — · ACTIVE_NOT_RECRUITING · sponsor: **Stanford University** · enrollment: 250 (estimated)

## Conditions studied

- Chronic Musculoskeletal Pain
- Pain
- Pain, Chronic
- Joint Pain

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04994249
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-21
- **Primary completion:** 2027-04-25
- **Final completion:** 2027-12-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04994249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04994249, "Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04994249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*